- Report
- February 2024
- 119 Pages
Global
From €7384EUR$7,950USD£6,178GBP
- Report
- June 2022
- 320 Pages
Global
From €12911EUR$13,900USD£10,801GBP
- Report
- March 2021
- 149 Pages
Global
From €6456EUR$6,950USD£5,401GBP
- Report
- April 2023
- 112 Pages
Global
From €4412EUR$4,750USD£3,691GBP
- Report
- August 2025
- 140 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- June 2025
- 400 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- October 2025
- 108 Pages
Australia
From €2786EUR$2,999USD£2,330GBP
- Report
- August 2025
- 171 Pages
Global
From €3343EUR$3,599USD£2,797GBP
- Report
- August 2025
- 150 Pages
Global
From €3343EUR$3,599USD£2,797GBP
- Report
- July 2025
- 350 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- July 2025
- 350 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- July 2025
- 350 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- July 2025
- 350 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- July 2025
- 350 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- June 2025
- 400 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- June 2025
- 400 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- October 2024
- 250 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- May 2023
- 147 Pages
Global
From €4597EUR$4,949USD£3,846GBP
- Report
- June 2025
- 190 Pages
Global
From €4640EUR$4,995USD£3,881GBP
- Report
- March 2024
- 136 Pages
Global
From €3948EUR$4,250USD£3,303GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more